摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-(4-methyl-cyclohex-3-enyl)-propan-1-ol | 74454-22-1

中文名称
——
中文别名
——
英文名称
1-(4-methyl-cyclohex-3-enyl)-propan-1-ol
英文别名
1-(4-Methylcyclohex-3-en-1-yl)propan-1-ol
1-(4-methyl-cyclohex-3-enyl)-propan-1-ol化学式
CAS
74454-22-1
化学式
C10H18O
mdl
——
分子量
154.252
InChiKey
FUIDPFVFDBDTSL-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.2
  • 重原子数:
    11
  • 可旋转键数:
    2
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.8
  • 拓扑面积:
    20.2
  • 氢给体数:
    1
  • 氢受体数:
    1

反应信息

点击查看最新优质反应信息

文献信息

  • THERAPEUTIC USES OF OLIGOMERIC AND POLYMERIC MONOTERPENES
    申请人:Hazan Zadik
    公开号:US20120213727A1
    公开(公告)日:2012-08-23
    The invention relates to therapeutic methods comprising use of oligomeric and polymeric forms of the monoterpene compounds alloocimene, limonene, alpha-pinene, beta-pinene, geranyl acetate, alpha-phellandrene, gamma-terpinene, 3-carene and 2-carene. More particularly, the invention relates to methods of treating degenerative neurological conditions, and treating skin disorders.
    本发明涉及使用单萜化合物alloocimene、limonene、alpha-pinene、beta-pinene、geranyl acetate、alpha-phellandrene、gamma-terpinene、3-carene和2-carene的寡聚体和聚合体形式的治疗方法。更具体地,本发明涉及治疗退行性神经疾病和治疗皮肤疾病的方法。
  • COMPOSITION FOR TOPICAL APPLICATION
    申请人:INSTITUTE FOR ADVANCED SKIN RESEARCH INC.
    公开号:EP0745389A1
    公开(公告)日:1996-12-04
    A composition for topical application comprising at least one surfactant having a nitrogen atom in the moiety thereof and at least one compound selected from the group consisting of cyclohexane and the derivatives thereof, cyclohexene and the derivatives thereof, and cyclohexanone and the derivatives thereof.
    一种外用组合物,包含至少一种分子中含有一个氮原子的表面活性剂和至少一种选自环己烷及其衍生物、环己烯及其衍生物和环己酮及其衍生物的化合物。
  • Monoterpene compositions and uses thereof
    申请人:Constantinides P Panayiotis
    公开号:US20060104997A1
    公开(公告)日:2006-05-18
    The present invention relates to pharmaceutical compositions and methods for the mucosal and oral administration of monoterpenes and derivatives thereof. The compositions of this invention further comprise one or more surfactants and cosolvents and are in the form of self-emulsifying compositions. The compositions of the invention may further comprise water-insoluble therapeutic agents, vaccines and diagnostics. Such agents include but are not limited to taxanes, steroids, topoisomerase inhibitors such as etoposide and other water-insoluble or lipophilic drugs.
    本发明涉及粘膜和口服单萜及其衍生物的药物组合物和方法。本发明的组合物进一步包含一种或多种表面活性剂和助溶剂,并采用自乳化组合物的形式。本发明的组合物可进一步包含水不溶性治疗剂、疫苗和诊断剂。这类药剂包括但不限于类固醇、类固醇、拓扑异构酶抑制剂(如依托泊苷)和其他不溶于水或亲脂性药物。
  • Petrow; Sopow, Zhurnal Obshchei Khimii, 1957, vol. 27, p. 1795,1797, 1804; engl. Ausg. S. 1862, 1864,1870
    作者:Petrow、Sopow
    DOI:——
    日期:——
  • POLYMERIC MONOTERPENES FOR TREATING IMPAIRED NEUROLOGICAL FUNCTION
    申请人:Regenera Pharma Ltd.
    公开号:EP2493461B1
    公开(公告)日:2016-01-06
查看更多